SCHEMBL9682167

SCHEMBL9682167

O=C(O)C1=CCC(c2ccccc2)(c2ccccc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
CYP2C9 P11712 1/20 0.48
KMT2A Q03164 1/20 0.48
AKR1C1 Q04828 1/20 0.39
OPRM1 P35372 3/20 0.37
HDAC4 P56524 4/20 0.36
DAO P14920 1/20 0.36
HTR2A P28223 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
TSHR P16473 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRR1 P24046 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038475 0.75 MEN1 (0.44) MEN1CYP2C9KMT2AAKR1C1OPRM1
SCHEMBL8253086 0.70 TSHR (0.37) GABRPGABRDGABRA1TSHRGABRB1
SCHEMBL3623734 0.69 TSHR (0.39) GABRPGABRDGABRA1TSHRGABRB1
SCHEMBL6862905 0.69 TSHR (0.39) GABRPGABRDGABRA1TSHRGABRB1
Bicarbonate SCHEMBL7575333 0.69 MEN1 (0.60) MEN1CYP2C9KMT2AAKR1C1OPRM1
SCHEMBL13185358 0.68 TSHR (0.38) CYP2C9GABRPGABRDGABRA1TSHR
SCHEMBL3401991 0.68 TSHR (0.42) AKR1C1GABRPGABRDGABRA1TSHR
SCHEMBL29403249 0.68 TSHR (0.42) GABRPGABRDGABRA1TSHRGABRB1
SCHEMBL23299696 0.67 TSHR (0.37) GABRPGABRDGABRA1TSHRGABRB1
SCHEMBL743693 0.66 MEN1 (1.00) MEN1CYP2C9KMT2AAKR1C1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175319-A Antiprotozoa agent, useful for treating malaria, theileriosis, coccidiosis and prophylaxix BURROUGHS WELLCOME CO. (US) 1992-12-29 US disclosed
US-5053432-A Antiprotozoa agents; treatment of malaria BURROUGHS WELLCOME CO. (US) 1991-10-01 US disclosed
EP-0123238-B1 NAPHTHOQUINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1987-06-10 EP disclosed
EP-0123238-A2 Naphthoquinone derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1984-10-31 EP disclosed